06.07.2016
- European regulators have approved the use of Amgen’s cancer drug Kyprolis in combination with just dexamethasone to treat certain adults with multiple myeloma, an incurable blood...
29.06.2016
- The US federal government’s National Institutes of Health (NIH) has declined a petition from a public interest group to lower the price of a drug for advanced prostate cancer...
06.06.2016
- The European Commission has granted approval for Novartis’ Afinitor (everolimus) for treating unresectable or metastatic, well-differentiated non-functional neuroendocrine tumors...
04.05.2016
- An R&D collaboration between Dublin, Ireland-based Nexvet Biopharma, a veterinary biologics developer, and Japanese animal health company Zenoaqa claims to have found fully...
29.04.2016
- As expected, French drugmaker Sanofi has made an unsolicited all cash, non-binding proposal bid to acquire US biopharmaceuticals firm Medivation. In a letter to the board of the...
27.04.2016
- US regulators have given a breakthrough designation to Bristol-Myers Squibb’s cancer drug Opdivo (nivolumab) for treating head and neck cancer. This is the fifth breakthrough...
22.04.2016
- US drugmaker Merck has gained Breakthrough Therapy Designation (BTD) from the US Food and Drug Administration (FDA) for Keytruda to treat patients with classical Hodgkin lymphoma...
14.04.2016
- Bristol-Myers Squibb’s cancer drug Opdivo can now be used to treat more patients with lung cancer or kidney cancer after European regulators expanded its indications. The EU...
